264 related articles for article (PubMed ID: 23835076)
1. Mechanisms of peptide repertoire selection by HLA-DM.
Pos W; Sethi DK; Wucherpfennig KW
Trends Immunol; 2013 Oct; 34(10):495-501. PubMed ID: 23835076
[TBL] [Abstract][Full Text] [Related]
2. Achieving stability through editing and chaperoning: regulation of MHC class II peptide binding and expression.
Busch R; Rinderknecht CH; Roh S; Lee AW; Harding JJ; Burster T; Hornell TM; Mellins ED
Immunol Rev; 2005 Oct; 207():242-60. PubMed ID: 16181341
[TBL] [Abstract][Full Text] [Related]
3. How HLA-DM affects the peptide repertoire bound to HLA-DR molecules.
Vogt AB; Kropshofer H; Hämmerling GJ
Hum Immunol; 1997 May; 54(2):170-9. PubMed ID: 9297535
[TBL] [Abstract][Full Text] [Related]
4. The impact of the non-classical MHC proteins HLA-DM and HLA-DO on loading of MHC class II molecules.
Kropshofer H; Hämmerling GJ; Vogt AB
Immunol Rev; 1999 Dec; 172():267-78. PubMed ID: 10631952
[TBL] [Abstract][Full Text] [Related]
5. HLA-DM and HLA-DO, key regulators of MHC-II processing and presentation.
Mellins ED; Stern LJ
Curr Opin Immunol; 2014 Feb; 26():115-22. PubMed ID: 24463216
[TBL] [Abstract][Full Text] [Related]
6. Selection of the MHC class II-associated peptide repertoire by HLA-DM.
Arndt SO; Vogt AB; Hämmerling GJ; Kropshofer H
Immunol Res; 1997; 16(3):261-72. PubMed ID: 9379076
[TBL] [Abstract][Full Text] [Related]
7. What to do with HLA-DO?
van Ham M; van Lith M; Griekspoor A; Neefjes J
Immunogenetics; 2000 Aug; 51(10):765-70. PubMed ID: 10970090
[TBL] [Abstract][Full Text] [Related]
8. What to do with HLA-DO/H-2O two decades later?
Welsh R; Song N; Sadegh-Nasseri S
Immunogenetics; 2019 Mar; 71(3):189-196. PubMed ID: 30683973
[TBL] [Abstract][Full Text] [Related]
9. Short peptide sequences mimic HLA-DM functions.
Chou CL; Mirshahidi S; Su KW; Kim A; Narayan K; Khoruzhenko S; Xu M; Sadegh-Nasseri S
Mol Immunol; 2008 Apr; 45(7):1935-43. PubMed ID: 18054387
[TBL] [Abstract][Full Text] [Related]
10. How HLA-DM works: recognition of MHC II conformational heterogeneity.
Sadegh-Nasseri S; Chou CL; Hartman IZ; Kim A; Narayan K
Front Biosci (Schol Ed); 2012 Jun; 4(4):1325-32. PubMed ID: 22652874
[TBL] [Abstract][Full Text] [Related]
11. HLA-DM recognizes the flexible conformation of major histocompatibility complex class II.
Chou CL; Sadegh-Nasseri S
J Exp Med; 2000 Dec; 192(12):1697-706. PubMed ID: 11120767
[TBL] [Abstract][Full Text] [Related]
12. Quantitative defect in staphylococcal enterotoxin A binding and presentation by HLA-DM-deficient T2.Ak cells corrected by transfection of HLA-DM genes.
Albert LJ; Denzin LK; Ghumman B; Bangia N; Cresswell P; Watts TH
Cell Immunol; 1998 Jan; 183(1):42-51. PubMed ID: 9578718
[TBL] [Abstract][Full Text] [Related]
13. DM and DO shape the repertoire of peptide-MHC-class-II complexes.
Karlsson L
Curr Opin Immunol; 2005 Feb; 17(1):65-70. PubMed ID: 15653313
[TBL] [Abstract][Full Text] [Related]
14. The structure of HLA-DM, the peptide exchange catalyst that loads antigen onto class II MHC molecules during antigen presentation.
Mosyak L; Zaller DM; Wiley DC
Immunity; 1998 Sep; 9(3):377-83. PubMed ID: 9768757
[TBL] [Abstract][Full Text] [Related]
15. Quality control of MHC class II associated peptides by HLA-DM/H2-M.
Vogt AB; Arndt SO; Hämmerling GJ; Kropshofer H
Semin Immunol; 1999 Dec; 11(6):391-403. PubMed ID: 10625593
[TBL] [Abstract][Full Text] [Related]
16. The mechanism of HLA-DM induced peptide exchange in the MHC class II antigen presentation pathway.
Schulze MS; Wucherpfennig KW
Curr Opin Immunol; 2012 Feb; 24(1):105-11. PubMed ID: 22138314
[TBL] [Abstract][Full Text] [Related]
17. HLA-DO increases bacterial superantigen binding to human MHC molecules by inhibiting dissociation of class II-associated invariant chain peptides.
Pezeshki AM; Azar GA; Mourad W; Routy JP; Boulassel MR; Denzin LK; Thibodeau J
Hum Immunol; 2013 Oct; 74(10):1280-7. PubMed ID: 23756162
[TBL] [Abstract][Full Text] [Related]
18. HLA-DO is a negative modulator of HLA-DM-mediated MHC class II peptide loading.
van Ham SM; Tjin EP; Lillemeier BF; Grüneberg U; van Meijgaarden KE; Pastoors L; Verwoerd D; Tulp A; Canas B; Rahman D; Ottenhoff TH; Pappin DJ; Trowsdale J; Neefjes J
Curr Biol; 1997 Dec; 7(12):950-7. PubMed ID: 9382849
[TBL] [Abstract][Full Text] [Related]
19. Conformational variation in structures of classical and non-classical MHCII proteins and functional implications.
Painter CA; Stern LJ
Immunol Rev; 2012 Nov; 250(1):144-57. PubMed ID: 23046127
[TBL] [Abstract][Full Text] [Related]
20. Identification of destabilizing residues in HLA class II-selected bacteriophage display libraries edited by HLA-DM.
Raddrizzani L; Bono E; Vogt AB; Kropshofer H; Gallazzi F; Sturniolo T; Hämmerling GJ; Sinigaglia F; Hammer J
Eur J Immunol; 1999 Feb; 29(2):660-8. PubMed ID: 10064083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
